J&J Without Consumer Health? Tylenol, Band-Aid Marketer Plans To Divest Business In Two Years
“As we watch the health care landscape continue to evolve, we think that it's only incumbent upon us to think about what kind of an impact that should have on our portfolio,” says CEO Alex Gorsky. The dependable revenue driver with iconic consumer health brands will be separated from J&J’s Rx drug and medical device division as a standalone, publicly traded company.
Johnson & Johnson's company name has been synonymous with consumer health care with its brands from Tylenol to Band-Aid and from Listerine to Neosporin holding high market shares for decades.
The consumer health business also has been synonymous to the firm as a “growth annuity” for reliable revenue even when...